THERAPEUTICS
Review: adding dexamethasone to standard therapy reduces short-term relapse for acute migraine in the emergency department
| The first 150 words of the full text of this article appear below. |
QUESTION
Does dexamethasone prevent relapse in patients presenting to the emergency department (ED) with acute migraine headache?
REVIEW SCOPE
Included studies evaluated adjuvant dexamethasone for acute migraine headache diagnosed and treated in the ED and reported the proportion of patients with self-reported moderate or severe headache at 24–72 hours as an outcome. Moderate or severe headache was defined as severe headache that interferes with daily activities or requires a physician visit (last 2 categories on a 5-point scale), moderate or severe headache (last 2 categories on a 4-point scale), or presence of headache on a dichotomous scale. Other outcomes included adverse events.
REVIEW METHODS
Randomised controlled trials (RCTs) in which patients and treating physicians were blinded were retrieved from Medline (1950–May 2008); EMBASE/Excerpta Medica, CINAHL, LILACS, and Cochrane Central Register of Controlled Trials {all to May 2008}*; ClinicalTrials.gov; reference lists; and abstracts from major emergency medicine conferences published in the past 7 years. Authors were
Parenteral Washington University in St. Louis, St Louis, Missouri, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
